Navigation Links
Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
Date:7/29/2008

16,418 48,205

Net cash provided by

operating activities 120,650 150,818

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of property and equipment (42,898) (50,283)

Acquisition of intangible assets (25,575) -

Investment in third party (6,242) -

Proceeds from sale of investment

in third party - 12,291

Sales and (purchases) of investments, net 7,596 18,040

Net cash used for investing activities (67,119) (19,952)

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from exercises of common

stock options 13,562 66,205

Windfall tax benefits from

stock-based compensation 480 8,681

Acquisition of treasury stock (24) (128)

Payments on and retirements of

long-term debt (215,129) (1,959)

Net cash provided by (used for)

financing activities (201,111) 72,799

EFFECT OF EXCHANGE RATE CHANGES

ON CASH AND CASH EQUIVALENTS 2,282 3,821

NET INCREASE (DECREASE) IN CASH AND

CASH EQUIVALENTS (145,298) 207,486

CASH AND CASH EQUIVALENTS,

BEGINNING OF PERIOD 818,669 496,512

CASH AND CASH EQUIVALENTS, END OF PERIOD $673,371 $703,998

CEPHALON, INC. AND SUBSIDIARIES

Reconciliation of Projected GAAP Basic Income per Common Share

to Basic Adjusted Income Per Common Share Guidance

(Unaudited)


'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... (PRWEB) December 13, 2014 According to ... million people between now and 2030." If a population ... the seventh most populous state in the country. , ... gathering at the Future of North Carolina Forum on ... Do we have the necessary infrastructure in place? Enough ...
(Date:12/13/2014)... Texas , Dec. 12, 2014  Vermillion, Inc. ... announced today the appointments of Veronica G. H. ... to the Company,s Board of Directors, bringing the total ... independent. Jim LaFrance , Chairman, ... am tremendously pleased to announce the appointments of Veronica ...
(Date:12/13/2014)... ROCHESTER, N.Y. , Dec. 12, 2014 ... engaged in the discovery and development of ... neurodegenerative diseases, today announced publication of a ... microglia, and inhibits remyelination in neurodegenerative disease" ... journal Neurobiology of Disease*.  The publication highlights ...
(Date:12/12/2014)... December 11, 2014 InSphero AG, the ... efficacy testing, announced today that data presented recently by ... microtissues as a more predictive model system for assessment ... the 2nd Annual Functional Analysis and Screening Technologies ... the response of InSphero’s 3D InSight™ Human Liver ...
Breaking Biology Technology:North Carolina Chamber of Commerce: Asking Questions & Gathering Answers with a Futurist 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Vaccinex announces publication of preclinical studies with an anti-SEMA4D antibody in animal models of neuroinflammatory and demyelinating disease 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 3
... PITTSBURGH, Oct. 7 Today the National Collegiate ... of BMEStart, an award recognizing undergraduate excellence in ... other biomedical competition (BMEidea) because of its focus ... much experience with product development. , The ...
... (Nasdaq: SGMO ) today announced the pricing of a ... The offering is expected to close on or about October ... In addition, Sangamo has granted the underwriter a 30-day ... common stock to cover over-allotments, if any. , ...
... , DUBLIN, October 7 , ... Only - , - Direct Comparison ... Efficacy , Shire plc (LSE: SHP, ... the publication in Clinical,Nephrology of findings from a head-to-head clinical ...
Cached Biology Technology:NCIIA Announces New Undergraduate Competition 2Sangamo Announces Pricing of Public Offering of Common Stock 2Sangamo Announces Pricing of Public Offering of Common Stock 3Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 2Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 3Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 4Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 5Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today 6
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
(Date:11/18/2014)... -- The Secure Identity & Biometrics Association (SIBA) and ... formation of The Airport Entry and Exit Working ... Biometric Entry and Exit Solutions Framework for Airports ... BORDERPOL, the international non-profit organization that works directly ... border security, traveler and migration systems. ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... stomach may be nearly as unique as your fingerprint, ... Medicine who have embarked on the early stages of ... detect all known types of microbes and borrowing statistical ... MD, a postdoctoral scholar in infectious diseases and geographic ...
... question of whether amino acids in sandwich-like proteins are ... the protein-folding process is best answered by "all of ... Houston. , This discovery, reported in today's issue of ... benefit future research on treatments for diseases related to ...
... Ebola virus reproduction in laboratory-grown cells is severely ... further study as possible treatments for Ebola virus ... by the National Institute of Allergy and Infectious ... of Health (NIH). , The researchers, whose paper ...
Cached Biology News:Stanford gut check shows diversity of intestinal ecosystem 2Stanford gut check shows diversity of intestinal ecosystem 3Conserved amino acids play both structural and mechanistic roles in sandwich-like protein 2Scientists discover how Ebola virus infects cells 2
... The ProteoExtract™ Protein Precipitation Kit is ... of proteins from aqueous samples. Proteomics ... the presence of non-protein impurities such ... the protein sample that interfere with ...
... luminometer provides the sensitivity and versatility you ... digital photon counting with selected photomultipliers ensure ... demands. Equipped with up to 2 reagent ... reporter gene assays as well as other ...
... high-speed analytical techniques, the AutoTrace SPE is a powerful, high-throughput workstation dedicated specifically ... loading and elution steps for large volumes aqueous solution extractions (up to 2000ml's). ... ... ...
... clear polystyrene with frosted labeling surfaces, ... cell counting. 100% integrity tested. Linkage: ... product number, created to easily match ... availability yet, please order under the ...
Biology Products: